相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant of concern breakthrough infections: Are vaccines failing us?
Ali Nowroozi et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2022)
Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
Meng Yuan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Spike mutation D614G alters SARS-CoV-2 fitness
Jessica A. Plante et al.
NATURE (2021)
Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion
Prabin Baral et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2
Dong-Kyun Ryu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry
Jiwan Ge et al.
NATURE COMMUNICATIONS (2021)
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape
Qianqian Li et al.
CELL (2021)
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Wanwisa Dejnirattisai et al.
CELL (2021)
The variant gambit: COVID-19's next move
Jessica A. Plante et al.
CELL HOST & MICROBE (2021)
Novel SARS-CoV-2 variants: the pandemics within the pandemic
Erik Boehm et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
SARS-CoV-2 Entry Related Viral and Host Genetic Variations: Implications on COVID-19 Severity, Immune Escape, and Infectivity
Szu-Wei Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
CORONAVIRUS VARIANTS ARE SPREADING IN INDIA - WHAT SCIENTISTS KNOW SO FAR
Gayathri Vaidyanathan
NATURE (2021)
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
Delphine Planas et al.
NATURE MEDICINE (2021)
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
Bryan E. Jones et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
Micah Rapp et al.
CELL REPORTS (2021)
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Chihiro Motozono et al.
CELL HOST & MICROBE (2021)
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
Yaniv Lustig et al.
EUROSURVEILLANCE (2021)
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas et al.
NATURE (2021)
SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern
Hyeseon Cho et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Insilico study on the effect of SARS-CoV-2 RBD hotspot mutants' interaction with ACE2 to understand the binding affinity and stability
Jyoti Verma et al.
VIROLOGY (2021)
The Spike of Concern-The Novel Variants of SARS-CoV-2
Anna Winger et al.
VIRUSES-BASEL (2021)
Covid-19: Are high rates of B.1.617.2 linked to vaccine hesitancy?
Gareth Iacobucci
BMJ-BRITISH MEDICAL JOURNAL (2021)
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann et al.
CELL REPORTS (2021)
SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India
Sarah Cherian et al.
MICROORGANISMS (2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
Chih-Cheng Lai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
A novel coronavirus outbreak of global health concern
Chen Wang et al.
LANCET (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies
Chunyan Yi et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System Celebrating the 20th Anniversary of the Discovery of ACE2
Mahmoud Gheblawi et al.
CIRCULATION RESEARCH (2020)
SARS-CoV-2 viral spike G614 mutation exhibits higher case fatality rate
Manuel Becerra-Flores et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19
Yuan Huang et al.
ACTA PHARMACOLOGICA SINICA (2020)
Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
Wanbo Tai et al.
ANTIVIRAL RESEARCH (2020)
Coronavirus membrane fusion mechanism offers a potential target for antiviral development
Tiffany Tang et al.
ANTIVIRAL RESEARCH (2020)
The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity
Qianqian Li et al.
CELL (2020)
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Bette Korber et al.
CELL (2020)
Geographic and Genomic Distribution of SARS-CoV-2 Mutations
Daniele Mercatelli et al.
FRONTIERS IN MICROBIOLOGY (2020)
Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant
Leonid Yurkovetskiy et al.
CELL (2020)
Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: Anin silicoinsight
Mohd Imran Khan et al.
PLOS ONE (2020)
Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development
Subodh Kumar Samrat et al.
VIRUS RESEARCH (2020)
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum et al.
ELIFE (2020)
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Liying Dong et al.
DRUG DISCOVERIES AND THERAPEUTICS (2020)
Energetic and exergetic performance assessment of the inclusion of phase change materials (PCM) in a solar distillation system
Mohamed S. Yousef et al.
ENERGY CONVERSION AND MANAGEMENT (2019)
POINTS OF SIGNIFICANCE Principal component analysis
Jake Lever et al.
NATURE METHODS (2017)
Mechanisms of viral mutation
Rafael Sanjuan et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Structure, Function, and Evolution of Coronavirus Spike Proteins
Fang Li
ANNUAL REVIEW OF VIROLOGY, VOL 3 (2016)
GMXPBSA 2.1: A GROMACS tool to perform MM/PBSA and computational alanine scanning
C. Paissoni et al.
COMPUTER PHYSICS COMMUNICATIONS (2014)
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
Sander Pronk et al.
BIOINFORMATICS (2013)
Coronaviruses post-SARS: update on replication and pathogenesis
Stanley Perlman et al.
NATURE REVIEWS MICROBIOLOGY (2009)